Literature DB >> 12879832

The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom.

Jennifer Hollowell1, Ana Ruigómez, Saga Johansson, Mari-Ann Wallander, Luis Alberto García-Rodríguez.   

Abstract

The aim of this study was to estimate and explore the incidence of warfarin-related bleeding in a representative sample of patients in the United Kingdom. We identified 3958 patients aged 40 to 84 years, newly treated with warfarin and with no prior history of bleeding from the General Practice Research Database, and followed them for 12 months. The overall incidence of first-time, idiopathic bleeding was 15.2 per 100 patient-years of current warfarin exposure: the incidence of fatal/hospitalised and referred bleeding was 3.5 and 2.6 per 100 patient-years, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879832      PMCID: PMC1314574     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  5 in total

Review 1.  Hemorrhagic complications of anticoagulant treatment.

Authors:  M N Levine; G Raskob; S Landefeld; C Kearon
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

2.  Audit of anticoagulant therapy.

Authors:  P E Rose
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

3.  The General Practice Research Database. Scientific and Ethical Advisory Group.

Authors:  D H Lawson; V Sherman; J Hollowell
Journal:  QJM       Date:  1998-06

4.  Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

Authors:  F J van der Meer; F R Rosendaal; J P Vandenbroucke; E Briët
Journal:  Arch Intern Med       Date:  1993-07-12

Review 5.  Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention.

Authors:  C S Landefeld; R J Beyth
Journal:  Am J Med       Date:  1993-09       Impact factor: 4.965

  5 in total
  12 in total

1.  A re-appraisal of warfarin control in the treatment of deep vein thrombosis and / or pulmonary embolism.

Authors:  C Amiwero; I A Campbell; R J Prescott
Journal:  Afr Health Sci       Date:  2009-09       Impact factor: 0.927

2.  Drug interactions with phenprocoumon and the risk of serious haemorrhage: a nested case-control study in a large population-based German database.

Authors:  Kathrin Jobski; Sigrid Behr; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2011-03-31       Impact factor: 2.953

Review 3.  Hepatic findings in long-term clinical trials of ximelagatran.

Authors:  William M Lee; Dominique Larrey; Rolf Olsson; James H Lewis; Marianne Keisu; Laurent Auclert; Sunita Sheth
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 4.  Warfarin reversal.

Authors:  J P Hanley
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

5.  Severity and Hospitalization Cost Related to Warfarin-Related Adverse Events in a Tertiary Malaysian Hospital.

Authors:  Doris George; Chung Aun Wong; Subramaniam Thanimalai; Hoo Seng Tan
Journal:  Hosp Pharm       Date:  2022-03-03

6.  Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey.

Authors:  Tim A Holt; Tina D Hunter; Candace Gunnarsson; Nada Khan; Paul Cload; Gregory Y H Lip
Journal:  Br J Gen Pract       Date:  2012-10       Impact factor: 5.386

7.  Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.

Authors:  Joseph A Delaney; Lucie Opatrny; James M Brophy; Samy Suissa
Journal:  CMAJ       Date:  2007-08-14       Impact factor: 8.262

8.  Predictors of warfarin-induced bleeding in a South Indian cardiology unit.

Authors:  Haritha Nekkanti; Uday Venkant Mateti; Rajesh Vilakkathala; Thiyagu Rajakannan; Surulivelrajan Mallayasamy; Ramachandran Padmakumar
Journal:  Perspect Clin Res       Date:  2012-01

9.  Retropharyngeal haematoma - an unusual bleeding site in an anticoagulated patient: a case report.

Authors:  Seema Srivastava; Tarun Solanki
Journal:  Cases J       Date:  2008-11-02

10.  Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?

Authors:  Otto Moodley; Hadi Goubran
Journal:  Thromb J       Date:  2015-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.